Search Results 251-260 of 15412 for TNF

1. A Study to Evaluate CPI-006 with Standard of Care vs. Placebo with Standard of Care in Mild-to-moderately Symptomatic Hospitalized Covid-19 Patients (Enrolling by Invitation Only) - Mayo Clinic

   Receipt of cancer chemotherapy or immunomodulatory drugs including (but not limited to) biologics such as anti-CD20, anti-TNF, anti-IL6; alkylating agents ...

2. A Study of Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease - Mayo Clinic

   ... TNF-α antagonist or vedolizumab or ustekinumab, or having documented intolerance. Women of childbearing potential (WCBP) must have negative serum pregnancy ...

3. Nutrition and healthy eating - Mayo Clinic

   You can master healthy eating by learning how to plan meals and shop smart, and by practicing healthy-cooking techniques.

4. A Study to Evaluate the Safety, Tolerability, and Clinical Benefit of AK002 in Adult Patients with Mast Cell Gastritis and/or Gastroenteritis

   ... TNF, anti-IL-5, anti-IL-5 receptor, dupilumab, anti-IgE antibodies, omalizumab) or systemic corticosteroids with a daily dose >10 mg of prednisone or ...

5. Physical Medicine and Rehabilitation Physicians - Medical Professionals - Mayo Clinic

   Find physical medicine and rehabilitation Physicians at your nearest Mayo Clinic location. Learn about the conditions they treat and procedures performed.

6. Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer - Mayo Clinic

   ... tumor necrosis factor [anti-TNF] agents) within 2 weeks prior to cycle 1, day 1: Patients who have received acute, low dose, systemic immunosuppressant ...

7. Publications - Patricio Escalante, M.D., M.S. - Mayo Clinic

   Diagnosis and Management of Latent Tuberculosis and Tuberculosis in Candidates for TNF-alpha Antagonist Therapy: An Expert Survey J of Mycobac Dis.2014, Oct ...

8. Untitled

   Page 1.

9. A Study to Evaluate Chemoradiotherapy with or without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer - Mayo Clinic

   ... tumor necrosis factor [anti-TNF] agents) within 14 days prior to randomization. Exceptions: Patients may have received acute, low dose, systemic ...

10. A Study to Evaluate the Effectiveness and Safety of Obeticholic Acid to Treat Patients with Primary Sclerosing Cholangitis - Mayo Clinic

    Subjects being administered biologic treatments (eg, anti-tumor necrosis factor (TNF) or anti-integrin monoclonal antibodies), immunosuppressants, systemic ...